drugset / Trial / NCT07019779
Study of CM518D1 in Patients With Advanced Solid Tumors
RandomizedParallel-groupOpen-labelTreatment
Summary
This is an interventional study to assess the safety, tolerability, efficacy, pharmacokinetics, and immunogenicity of CM518D1 in patients with advanced solid tumors.
Timeline
- Start
- 2025-06-27
- Primary completion
- 2028-12-31
- Completion
- 2029-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CM518D1 | Unknown | — | Intravenous |